Renal ischemia reperfusion injury (IRI) is associated with significant morbidity and mortality. Given the importance of microRNAs (miRNAs) in regulating gene expression, we examined expression profiles of miRNAs following renal IRI. Global miRNA expression profiling on samples prepared from the kidneys of C57BL/6 mice that underwent unilateral warm ischemia revealed nine miRNAs (miR-21, miR-20a, miR-146a, miR-199a-3p, miR-214, miR-192, miR-187, miR-805, and miR-194) that are differentially expressed following IRI when compared with sham controls. These miRNAs were also differently expressed following IRI in immunodeficient RAG-2/ common γ-chain double-knockout mice, suggesting that the changes in expression observed are not significantly influenced by lymphocyte infiltration and therefore define a lymphocyte-independent signature of renal IRI. In vitro studies revealed that miR-21 is expressed in proliferating tubular epithelial cells (TEC) and up-regulated by both cell-intrinsic and -extrinsic mechanisms resulting from ischemia and TGF-β signaling, respectively. In vitro, knockdown of miR-21 in TEC resulted in increased cell death, whereas overexpression prevented cell death. However, overexpression of miR-21 alone was not sufficient to prevent TEC death following ischemia. Our findings therefore define a molecular fingerprint of renal injury and suggest miR-21 may play a role in protecting TEC from death.kidney | miR-21 | tubular epithelial cells | programmed cell death protein 4 I schemic injury followed by reperfusion results in the clinical syndrome of acute kidney injury, a common clinical problem (1-4). The initial nonimmune hypoxic injury and subsequent reperfusion leads to activation of innate and adaptive immune responses, resulting in tissue damage (5). Following injury, a repair process involving cellular proliferation must take place to regain renal function (6). Ischemia reperfusion injury (IRI) is also inevitable in kidney transplantation and contributes to delayed graft function and long-term changes in kidney transplants that affect outcome (7-9). Although IRI is clearly a major clinical problem in native kidneys and in the setting of renal transplantation, the pathogenesis of renal IRI is not fully understood.MicroRNAs (miRNAs) are a class of small, noncoding RNAs ≈21-22 nucleotides in length that regulate gene expression and many disease processes (10, 11). A role for miRNAs in kidney disease is rapidly emerging (12). Numerous hallmarks of IRI (9), such as apoptosis (13), fibrosis (14), epithelial-mesenchymal transition (15), and TLR signaling (16), are regulated by miRNAs in other settings. Recent work has also revealed a role for miRNAs in the regulation of cardiac (13) and hepatic IRI (17).We hypothesized that miRNA expression patterns may serve as a biomarker of kidney injury. To test this hypothesis we reasoned that it would be necessary to examine miRNA expression patterns in an unbiased manner and examine whether differences in miRNA expression patterns were the result of lymphocyte in...